v3.26.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2024 $ 398 $ 57,453,920 $ (65,086,200) $ (7,631,882)
Balance, shares at Dec. 31, 2024 398,256        
Series A compensation expense 164,063 164,063
Conversion of Series D Preferred stock $ (89) 89
Conversion of Series D preferred Stock to common stock, shares   (88,334)        
Effect of reverse stock split round lot shares
Net loss (5,059,256) (5,059,256)
Issuance of common stock for liabilities settlement 2,597,427 2,597,427
Issuance of Series D preferred stock in connection with loans – working capital, net $ 19 190,352 190,371
Issuance of Series D preferred stock in connection with loans - working capital, net, shares   18,736        
Issuance of common stock in connection with consulting and financing arrangements 2,206 2,206
Conversion of notes payable into Common Stock 1,724,398 1,724,398
Conversion of notes payable into common stock, shares          
Balance at Mar. 31, 2025 $ 328 62,132,455 (70,145,456) (8,012,673)
Balance, shares at Mar. 31, 2025 328,658        
Balance at Dec. 31, 2024 $ 398 57,453,920 (65,086,200) (7,631,882)
Balance, shares at Dec. 31, 2024 398,256        
Net loss           (23,196,999)
Balance at Jun. 30, 2025 $ 289 85,155,019 (88,283,199) (3,127,891)
Balance, shares at Jun. 30, 2025 154 289,378        
Balance at Mar. 31, 2025 $ 328 62,132,455 (70,145,456) (8,012,673)
Balance, shares at Mar. 31, 2025 328,658        
Series A compensation expense 164,063 164,063
Issuance of Series D preferred stock and common stock for liabilities settlement $ 79 4,136,725 4,136,804
Issuance of Series D preferred stock and common stock for liabilities settlement, shares 54 79,000        
Conversion of Series D Preferred stock $ (118) 118
Conversion of Series D preferred Stock to common stock, shares 1 (118,280)        
Offering costs (380,251) (380,251)
Net loss (18,137,743) (18,137,743)
Conversion of notes payable into Common Stock 16,601,909 16,601,909
Conversion of notes payable into common stock, shares 87          
Issuance of Common stock in private placement 2,500,000 2,500,000
Issuance of common stock in private placement, shares 12          
Balance at Jun. 30, 2025 $ 289 85,155,019 (88,283,199) (3,127,891)
Balance, shares at Jun. 30, 2025 154 289,378        
Balance at Dec. 31, 2025 $ 3 $ 1,521 103,791,736 (99,411,489) 4,381,771
Balance, shares at Dec. 31, 2025 3,362 1,521,701        
Series A compensation expense 62,500 62,500
Issuance of Series D preferred stock and common stock for notes payable settlement $ 45 $ 282 6,965,791 6,966,118
Issuance of Series D preferred stock and common stock for notes payable settlement, shares 45,220 281,560        
Issuance of Series D preferred stock $ 70 524,930 525,000
Issuance of Series D preferred stock, shares   70,000        
Issuance of Series D preferred stock and common stock for liabilities settlement $ 8 $ 53 1,984,440 1,984,501
Issuance of Series D preferred stock and common stock for liabilities settlement, shares 7,781 53,334        
Issuance of Series D preferred stock and common stock for consulting services $ 18 134,982 135,000
Issuance of Series D preferred stock and common stock for consulting services, shares   18,000        
Conversion of Series D Preferred stock $ 90 $ (861) (3,443) (4,214)
Conversion of Series D preferred Stock to common stock, shares 89,820 (860,843)        
Issuance of Series E preferred stock for preferred returns 120,234 (120,234)
Issuance of Series E preferred stock for preferred returns, shares   119        
Conversion of Series E preferred stock to common stock $ 25 (2) 23
Conversion of Series E preferred stock to common stock, shares 24,500 (490)        
Offering costs (30,000) (30,000)
Effect of reverse stock split round lot shares $ 63 19,268 19,331
Effect of reverse stock split round lot shares, shares 62,683          
Net loss (6,853,464) (767) (6,854,231)
Balance at Mar. 31, 2026 $ 233 $ 1,083 113,570,436 (106,385,187) (767) 7,185,798
Balance, shares at Mar. 31, 2026 233,366 1,083,381        
Balance at Dec. 31, 2025 $ 3 $ 1,521 103,791,736 (99,411,489) 4,381,771
Balance, shares at Dec. 31, 2025 3,362 1,521,701        
Net loss           (12,835,048)
Balance at Jun. 30, 2026 $ 21,004 $ 762 115,932,812 (112,367,197) (13,575) 3,573,806
Balance, shares at Jun. 30, 2026 21,004,164 762,001        
Balance at Mar. 31, 2026 $ 233 $ 1,083 113,570,436 (106,385,187) (767) 7,185,798
Balance, shares at Mar. 31, 2026 233,366 1,083,381        
Series A compensation expense 62,500 62,500
Conversion of Series D Preferred stock $ 1,599 $ (320) (1,279)
Conversion of Series D preferred Stock to common stock, shares 1,598,755 (319,751)        
Issuance of Series E preferred stock for preferred returns $ 1 14,000 (14,001)
Issuance of Series E preferred stock for preferred returns, shares   14        
Conversion of Series E preferred stock to common stock $ 5,272 $ (2) (5,270)
Conversion of Series E preferred stock to common stock, shares 5,271,983 (1,643)        
Effect of reverse stock split round lot shares $ 3,221 (3,221)
Effect of reverse stock split round lot shares, shares 3,220,683          
Net loss (5,968,009) (12,808) (5,980,817)
Conversion of Series A preferred stock to common stock
Exercise of warrants
Issuance of common stock for notes payable settlement $ 9,129 1,821,046 1,830,175
Issuance of common stock for notes payable settlement, shares 9,129,377          
Issuance of common stock for liabilities settlement $ 1,550 474,600 476,150
Issuance of common stock for liabilities settlement, shares 1,550,000          
Balance at Jun. 30, 2026 $ 21,004 $ 762 $ 115,932,812 $ (112,367,197) $ (13,575) $ 3,573,806
Balance, shares at Jun. 30, 2026 21,004,164 762,001